The Trypanosoma cruzi cryobank is a curated collection of viable parasite stabilates preserved at −150 °C to ensure long-term conservation of biological material for Chagas disease research. Each record corresponds to a unique isolate or biological clone (when applicable) linked to a documented chain of custody from field or laboratory collection through isolation, stabilisation, storage, and subsequent withdrawals.
The Trypanosoma cruzi cryobank is documented through a harmonised metadata structure designed to ensure traceability, scientific usability, and long-term conservation of parasite diversity. For each isolate or biological clone, the database records a stable internal identifier (Tri), laboratory code, isolate name, species (T. cruzi), and DTU assignment (TcI–TcVI when available), together with associated references or source publications. Geographical provenance is described at multiple administrative levels (country, département, province, communauté/locality) and includes information on ecological origin (domestic, peridomestic, sylvatic or mixed transmission context).
The host and epidemiological context are specified through host species, taxonomic order, common name, transmission cycle classification, and date of parasite isolation. Laboratory-related information includes current culture status and available biological characterisation data (e.g., molecular typing markers, sequencing accession numbers, or relevant phenotypic traits). Cryopreservation metadata document the date of stabilisation, core elements of the cryopreservation protocol (cryoprotectant, freezing procedure, storage at −150 °C), and precise physical storage coordinates within the freezer system (rack, box, row, column). Stock verification and quality control status are recorded to ensure traceability and integrity of stored material.
The cryobank is designed to:
- Preserve the genetic and phenotypic diversity of T. cruzi across geographic regions, host species, and transmission cycles.
- Provide reference biological material for experimental research, method validation, and comparative studies.
- Enable controlled access to well-documented parasite resources under appropriate biosafety, ethical, and material transfer frameworks.
The cryobank operates in accordance with applicable access and benefit-sharing (ABS) regulations, including the Nagoya Protocol.
(2026-01-27)